Primary resistance is mainly attributed to TME alterations, which involve mutations and co-mutations, modulation of T cell infiltration, enrichment of M2 tumor-associated macrophages (M2-TAMs), vascular endothelial growth factor (VEGF), pulmonary fibrosis and mucosal-associated invariant T (MAIT) cells. This evidence concerns the gene VEGFA and neoplasm.